News
BACK
3.550
+7.58%
0.250
Immutep, Capricor Therapeutics, Cyclacel Pharmaceuticals among healthcare movers
Immutep, Capricor Therapeutics, Cyclacel Pharmaceuticals among healthcare movers. S&P 500 Health Care Sector -0.08% to 1644.11. Pharmaceuticals, Biotechnology & Life Science contributes 58% to the index.
Seeking Alpha · 3h ago
BACK, ZPTA and ABVC are among premarket gainers
BranchOut Food (BOF) and ZPTA and ABVC are among premarket gainers. Amesite (AMST) launches a revolutionary nurseMagic app. Tesla (TSLA) has analysts buzzing after Elon Musk says it is now an AI robotics company.
Seeking Alpha · 4h ago
Weekly Report: what happened at BACK last week (0415-0419)?
Weekly Report · 2d ago
(BACK) - Analyzing IMAC Hldgs's Short Interest
IMAC Hldgs's short percent of float has risen 1447.53% since its last report. The company has 880 thousand shares sold short, which is 84.65% of all regular shares available for trading. Short interest is the number of shares that have been sold short but have not yet been covered.
Benzinga · 4d ago
Predictive Oncology, BIMI Holdings, IMAC Holdings among healthcare movers
Seeking Alpha · 5d ago
Financial Report Articles: Lease and Asset Utility Analysis
Press release · 04/16 23:33
IMAC Holdings Inc reports results for the quarter ended in December - Earnings Summary
IMAC Holdings Inc reports results for the quarter ended in December. The company reported a quarterly adjusted loss of $1.31 per share. Revenue fell 94.4% to $194.00 thousand from a year ago. Shares had risen by 9.5% this quarter and 51.6% so far this year.
Reuters · 04/16 22:24
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Sk Skillsoft Corp. Shares dipped 26.7% to $6.74 on Tuesday. The company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. WiSA Technologies, Inc. Shares jumped 85% after the company announced a licensing agreement with an HDTV/PTV brand.
Benzinga · 04/16 18:17
Palisade Bio, Marinus Pharmaceuticals, Poseida Therapeutics among healthcare movers
Healthcare On the Move: Palisade Bio, Marinus Pharmaceuticals, Poseida Therapeutics among healthcare movers. S&P 500 Health Care Sector +0.08% to 1617.11. Health Care Equipment & Services among healthcare mover.
Seeking Alpha · 04/16 14:00
Weekly Report: what happened at BACK last week (0408-0412)?
Weekly Report · 04/15 09:44
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Eliem Therapeutics (NASDAQ:ELYM) stock moved upwards by 51.6% to $4.05 during Thursday's pre-market session. Rallybio stock increased by 49.07% and Alpine Immune Sciences stock rose 36.62% during the same period.
Benzinga · 04/11 12:10
12 Health Care Stocks Moving In Wednesday's After-Market Session
Rallybio shares rose 31.9% to $2.15 during Wednesday's after-market session. The company's market cap stands at $81.2 million. Vera Therapeutics (NASDAQ:VERA) shares increased by 10.52% during the session.
Benzinga · 04/10 20:31
Weekly Report: what happened at BACK last week (0401-0405)?
Weekly Report · 04/08 09:46
Weekly Report: what happened at BACK last week (0325-0329)?
Weekly Report · 04/01 09:46
IMAC Holdings Inc <BACK.OQ> expected to post a loss of 73 cents a share - Earnings Preview
IMAC Holdings Inc. Expected to post a loss of 73 cents a share - Earnings Preview. The Brentwood Tennessee-based company is expected to report a 71.2% decrease in quarterly revenue to $1 million. The one available analyst rating on the shares is "buy"
Reuters · 03/27 20:20
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Stoke Therapeutics (NASDAQ:STOK) stock increased by 80.2% to $11.71 during Tuesday's pre-market session. The company's, Q4 earnings came out yesterday. OpGen shares moved upwards by 77.6% and Praxis Precision Medicine (PRAX) shares increased by 21.38%. ABVC BioPharma (ABVC) and Sutro Biopharma (STRO) were among the losers.
Benzinga · 03/26 13:05
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Cannabis legalization, drug approval, a delisting update and more are the biggest pre-market stock movers on Monday morning. Next e GO stock is rocketing more than 127% alongside heavy pre- market trading this morning. Salarius Pharmaceuticals shares are surging over 28% following cannabis legalization in Germany. The top 10 biggest losers include a company undergoing a reverse stock split.
Investorplace · 03/25 11:36
Weekly Report: what happened at BACK last week (0318-0322)?
Weekly Report · 03/25 09:47
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Cutera, Inc. Fell sharply on Friday after the company reported worse-than-expected fourth quarter adjusted EPS results. Murano Global Investments PLC shares jumped 147.5% to $23.94 after falling 46% on Thursday. Other stocks moving in today's mid-day session include Nova LifeStyle, Inc., Worthington Steel and Foot Locker.
Benzinga · 03/22 18:39
BUZZ-U.S. STOCKS ON THE MOVE-Reddit, Alphabet, Tesla
The blue-chip Dow and the benchmark S&P 500 eased on Friday, but are still on track for strong weekly gains. Investors cheered the Federal Reserve's rate-easing stance. Reddit, Alphabet and Tesla were among the biggest losers on Wall Street. The Dow Jones Industrial Average was down 0.46% and the Nasdaq Composite was up.
Reuters · 03/22 17:59
More
Webull provides a variety of real-time BACK stock news. You can receive the latest news about Imac Hldgs Inc through multiple platforms. This information may help you make smarter investment decisions.
About BACK
IMAC Holdings, Inc. owns and manages health and wellness centers that delivers sports medicine, orthopedic care, and restorative joint and tissue therapies for movement restricting pain and neurodegenerative diseases. The Company provides movement, orthopedic and neurological therapies through its chain of Innovative Medical Advancements and Care (IMAC) Regeneration Centers. The Company, through its outpatient medical clinics, provide conservative, minimally invasive medical treatments to help patients with back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. It operates through two business segments: outpatient medical centers and clinical research division. The Company's research division is conducting a Phase I clinical trial evaluating a mesenchymal stem cell therapy candidate for bradykinesia due to Parkinson’s disease. The Company operates approximately 10 outpatient medical clinics in five states in the United States.